Jun 29, 2026 08:01AM
Jun 29, 2026 08:00AM
May 27, 2026 08:00AM
May 27, 2026 08:00AM
May 13, 2026 04:05PM
May 13, 2026 04:05PM
May 6, 2026 08:01AM FDA accepts Nuvation Bio supplemental application for IBTROZI
May 6, 2026 08:00AM
May 4, 2026 04:10PM
Apr 27, 2026 08:00AM
Apr 21, 2026 06:00PM
Apr 1, 2026 08:01AM
Apr 1, 2026 08:00AM
Mar 27, 2026 08:50AM Eisai and Nuvation Bio get EU validation for lung cancer drug filing
Mar 27, 2026 06:46AM
Mar 26, 2026 04:05PM
Mar 26, 2026 04:05PM
Mar 17, 2026 04:35PM
Mar 2, 2026 04:05PM
Feb 9, 2026 08:00AM
Feb 9, 2026 08:00AM Nuvation Bio Announces Pivotal Global Phase 3 SIGMA Trial (G203) for Safusidenib in IDH1-Mutant Glioma
Feb 4, 2026 06:50AM
Jan 12, 2026 08:04AM
Jan 12, 2026 08:00AM
Jan 12, 2026 07:33AM
Jan 12, 2026 07:30AM
Dec 3, 2025 08:00AM
Dec 3, 2025 08:00AM Nuvation Bio Announces Publication of Positive Phase 2 Study Results for Safusidenib for the Treatment of Grade 2 IDH1-Mutant Glioma in Neuro-Oncology
Nov 24, 2025 07:33AM
Nov 19, 2025 01:02AM
Nov 3, 2025 04:05PM
Oct 23, 2025 07:31AM
Oct 23, 2025 07:30AM
Sep 30, 2025 07:30AM
Sep 30, 2025 07:30AM Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI™ (taletrectinib) for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer
Sep 30, 2025 02:04AM
Sep 19, 2025 07:30AM
Sep 19, 2025 07:30AM
Sep 11, 2025 08:18AM
Sep 7, 2025 06:00AM
Aug 7, 2025 07:30AM
Aug 5, 2025 08:00AM Nuvation Bio To Present New Data on IBTROZI™ (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at WCLC and ESMO Annual Congresses
Jun 24, 2025 07:00AM
Jun 13, 2025 06:44AM
Jun 13, 2025 05:31AM
Jun 12, 2025 04:13AM
Jun 11, 2025 01:20PM
Jun 11, 2025 01:20PM
Jun 11, 2025 12:55PM Nuvation Bio (NUVB) said granted FDA approval for Ibtrozi for non-small cell lung cancer
May 21, 2025 04:05PM

325,517 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All